ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,378Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 1290

$1.45M Total Retail Price of All Prescriptions

Rank: 22 out of 1290

1,499 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 1,499 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

7% of this provider’s 10,819 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$117 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

8 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 1,118 1,019 1 4
METFORMIN HCL 761 689 2 10
SYNTHROID 651 583 3 28
GLYBURIDE 619 566 R 10 4 87
INSULIN SYRINGE 605 550 10 5 76
PEN NEEDLE 536 476 6 72
SIMVASTATIN 378 320 7 1
HUMULIN 70-30 281 277 8 240
LANTUS 275 232 9 67
HUMALOG 266 186 10 148
LISINOPRIL 257 198 11 5
HUMULIN N 251 221 12 332
LANTUS SOLOSTAR 251 208 12 88
GLIMEPIRIDE 244 227 14 57
LOSARTAN POTASSIUM 191 156 15 19
NOVOLIN 70-30 186 160 16 233
HUMULIN R 173 136 17 347
GLIPIZIDE 172 163 18 81
METFORMIN HCL ER 170 166 19 135
NOVOLOG MIX 70-30 FLEXPEN 158 139 20 213
NOVOLOG FLEXPEN 154 143 21 129
HUMALOG MIX 75-25 144 139 22 316
GLIPIZIDE ER 139 135 23 206
ATORVASTATIN CALCIUM 137 127 24 23
GLYBURIDE-METFORMIN HCL 131 125 R 25 147
GABAPENTIN 118 97 26 8
ONGLYZA 114 98 27 263
METHIMAZOLE 110 96 28 232
CRESTOR 109 82 29 17
METOPROLOL TARTRATE 94 93 30 7
ZOLPIDEM TARTRATE 90 50 31 15
NOVOLOG 90 82 31 167
GLIPIZIDE XL 86 76 33 381
PRAVASTATIN SODIUM 86 80 33 42
LOVASTATIN 81 60 35 45
JANUVIA 79 73 36 82
NOVOLIN N 77 73 37 411
LEVEMIR FLEXPEN 74 72 38 172
AMLODIPINE BESYLATE 69 67 39 3
LEVOXYL 65 64 40 224
RAMIPRIL 61 60 41 136
BYETTA 55 34 42 378
OMEPRAZOLE 55 43 42 2
DIOVAN 55 48 42 53
NATEGLINIDE 53 50 45 280
CALCITRIOL 53 43 45 142
LIOTHYRONINE SODIUM 51 41 47 494
FENOFIBRATE 51 46 47 98
NOVOLIN R 50 44 49 303
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 26, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.